Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 7Neoplasms 4Cognitive Dysfunction 4Stroke 2Pain 2Neurofibromatosis 1 2Fatigue 2Depression 2Cancer Pain 2Vomiting 1Spinal Cord Diseases 1Smoking Cessation 1Smoking 1Radiculopathy 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Nausea 1Motor Activity 1Lymphoma, Follicular 1Hemianopsia 1Head and Neck Neoplasms 1Endometriosis 1Dyspareunia 1Dysmenorrhea 1Cognition Disorders 1Carcinoma, Hepatocellular 1Breast Cancer Survivors 1Brain Neoplasms 1Brain Injuries, Traumatic 1Bone Neoplasms 1

Interventions

AZD 6244 19trametinib 5Lovastatin 5Deoxycholic Acid 4mirdametinib 3Lasers, Solid-State 3pirfenidone 2fludarabine 2binimetinib 2Vincristine 2Vinblastine 2Transcranial Direct Current Stimulation 2Specimen Handling 2Sirolimus 2Polidocanol 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Lasers 2Lamotrigine 2Inhalation 2Everolimus 2Carboplatin 2Biopsy 2Acetylcysteine 2tipifarnib 1thymoglobulin 1talimogene laherparepvec 1pomalidomide 1peginterferon alfa-2b 1omipalisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neurofibromatosis 1 × Transcranial Direct Current Stimulation × Clear all
NCT04991428 2021-08-05

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

University of Manchester

Phase NA Completed
31 enrolled
CNS

Neurofibromatosis 1

NCT03310996 2019-04-24

tDCS is NF1

University of Manchester

Phase NA Completed
16 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡